yeah, but, once approved for MF of MDS, doctors will prescribe Imetelstat for other blood cancers as well, dont you think? so a 30 year trial isnt really necessary.
wow. did not know about the liability issue. thanks for the clarification. guess they could try and get other indications studied after they get their foot in the door and get Imetelstat approved for MDS and MF.
why don't YOU compose a list of "things" you have clearly and substantially done in 2015. And in terms of positives for this company, I wouldn't list your incessant whining and unrelenting subversion of confidence in the company among share holders.
Is it the type of conference in which big news is released? Or, when an announcement is ready to be made, will it come in the form of a sudden press release or high target conference, such as ASH? I honestly don't know, but it seems like everyone gets pumped for these investor meet and greets and nothing new really comes out of them. Please educate me.
When he speaks, he's not just talking to you, though you and your money is listening to him. He is also talking to the bigger fish in the audience, who are thinking of investing ten to 100 fold what average individual investor is thinking of investing. And, more importantly, he is also talking to Johnson and Johnson. He is telling them this: We are not just a one drug property for you to buy. We are not just teeing the golf ball up for you to swing at. We fully intend on becoming the next Amgen...Celgene...Gilead...and as a consequence, when you make your bid, you will be bidding not for a single drug, but for the potential of a biotech powerhouse with not only a first to market breakthrough therapy, but an inventory of patents, potential applications, and complimentary subsidiaries (acquisitions). If you want us, you will have to pony up. And for sure, Scarlett maybe has intimated this to JnJ -- though cant be heavy handed about it, seeing as Imetelstat isnt even approved yet, that would be a bit presumptuous -- but whether they have or not, you start laying the foundation for that reality, you mention acquistions time after time in your CCs and other prospecti. You register a shelf. You look at other companies. You make the case. You are worth potentially a LOT...all without ever spending a dime. And JnJ follows what you say in the press and conference calls. they want to know what's up with their investment just like the rest of us. So it could be Scarlett isnt even talking to the eggheads on this petty message board who argue day in/day out about his worth...he could be talking to someone else.
What does this mean?
Didn't Taz already post this? It's the same news release, right?
ClinicalTrials still has the Study listed as Closed. Where do you see it open? Lies and false hope do more damage in the end than no news at all.
with his track record of divorce and bankruptcy, I seriously doubt he'd have the same wife at the end of 8 years that he started with...probably be on his 5th or 6th by that point.
wowzers...they're getting ready for mass production. not sure if this is to make roll out in clinics easier or if this device would be for administering the pharma (imetelstat) at home...which would be huge compared to having to go into a clinic.
they only need one or two dosage levels to make containers for.
just noticed this patent is from several years ago...not sure if they are getting ready for roll out or already got ready.
im pretty sure i was wrong. this is a storage device to keep imetelstat stocked at a clinic.